Related Experiment Video

Updated: Apr 28, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

9.3K

PAR-4: a possible new target for age-related disease

Wu Qinan1, Zhang Ling, Chen Bing

  • 1The First Affiliated Hospital of the Third Military Medical University, Endocrine Department , Post number: 400038, Chongqing , China chenbingxnyy@126.com.

Expert Opinion on Therapeutic Targets
|June 4, 2014
PubMed
Abstract

Insights

Prostate apoptosis response-4 (PAR-4) is crucial in age-related diseases and apoptosis. Targeting PAR-4 offers a potential therapeutic strategy for these conditions, particularly in cancer cells.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Gerontology

Background:

  • Apoptosis is vital in age-related diseases.
  • Prostate apoptosis response-4 (PAR-4) is a key apoptosis-inducing factor.
  • PAR-4's role in age-related disease progression is increasingly recognized.

Purpose of the Study:

  • To review advancements in PAR-4 research over the last 15 years.
  • To highlight PAR-4's significance in age-related diseases.
  • To explore PAR-4 as a potential therapeutic target.

Main Methods:

  • Literature review of studies on PAR-4 and age-related diseases.
  • Analysis of PAR-4's involvement in apoptotic signaling pathways.
  • Examination of PAR-4's role in endoplasmic reticulum (ER) stress.

Main Results:

  • PAR-4 is implicated in various age-related disease mechanisms.
  • ER stress induces PAR-4 expression.
  • PAR-4 is linked to dopamine D2 receptor activity.

Conclusions:

  • PAR-4 is a promising therapeutic target for selective apoptosis induction in cancer cells.
  • Abnormal PAR-4 expression is associated with cardiovascular disease and diabetes.
  • Identification of PAR-4 agonists and inhibitors is necessary for gene therapy.
Keywords:
age-related diseaseapoptosisendoplasmic reticulum stressprostate apoptosis response-4

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

7.7K

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
366
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K